test · 181 papers with claims · 107 for outreach · 56 old · 18 reviews
<2016
Filtered out
Partial Reprogramming As An Emerging Strategy for Safe Induced Cell Generation and Rejuvenation.
Can iPSCs Turn Back Time? Prospects and Pitfalls in Age Reversal.
Partial cellular reprogramming stably restores the stemness of senescent epidermal stem cells.
Synergistic Anti-Ageing through Senescent Cells Specific Reprogramming.
Partial Reprogramming Is Conserved from Insect to Mammal.
Partial Cell Fate Transitions to Promote Cardiac Regeneration.
The E1a Adenoviral Gene Upregulates the Yamanaka Factors to Induce Partial Cellular Reprogramming.
Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.
Partial Reprogramming Exerts a Rejuvenating Effect on Human Mesenchymal Stem Cells That Underwent Replicative Senescence
Nanoparticles: Taking a Unique Position in Medicine
Oxygen: A Stimulus, Not "Only" a Drug.
Epigenetic rejuvenation by partial reprogramming.
Partial Reprogramming in Senescent Schwann Cells Enhances Peripheral Nerve Regeneration via Restoration of Stress Granul
Epithelial‐mesenchymal Transition and Cancer Stem Cells: At the Crossroads of Differentiation and Dedifferentiation
Indirect Mechanisms of Transcription Factor-Mediated Gene Regulation during Cell Fate Changes.
Bone Aging, Cellular Senescence, and Osteoporosis
Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells.
Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo.
A Highly Conductive 3D Cardiac Patch Fabricated Using Cardiac Myocytes Reprogrammed from Human Adipogenic Mesenchymal St
Cocktail of chemical compounds robustly promoting cell reprogramming protects liver against acute injury.
Conserved biological processes in partial cellular reprogramming: Relevance to aging and rejuvenation.
The Pathobiology of Skin Aging
Targeted partial reprogramming as a novel therapeutic strategy for age-related decline.
The epigenetic rejuvenation promise: Partial reprogramming as a therapeutic strategy for aging and disease.
Transient or partial epigenetic reprogramming to overcome senescence in human keratinocyte cultures for skin engineering
In vivo partial cellular reprogramming enhances liver plasticity and regeneration.
In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Prevalent mesenchymal drift in aging and disease is reversed by partial reprogramming.
Diverse partial reprogramming strategies restore youthful gene expression and transiently suppress cell identity.
A new hypothetical model for pancreatic development based on change in the cell division orientation.
Rejuvenation of the Aging Heart: Molecular Determinants and Applications.
Unlocking regeneration: how partial reprogramming resembles tissue healing.
Reprogramming endothelial and vascular smooth muscle cells to prevent and treat hypertension.
Age reprogramming: cell rejuvenation by partial reprogramming.
Krüppel-like factors in mammalian stem cells and development
Mammalian Blastema: Possibility and Potentials.
The Role of Microenvironment in Preserving the Potency of Adult Porcine Pulmonary Valve Stem Cells In Vitro.
Hepatocyte-specific partial cellular reprogramming via selective OSK mRNA lipid nanoparticle attenuates liver fibrosis.
Anti-aging strategies and ex vivo organ rejuvenation.
Cognitive rejuvenation through partial reprogramming of engram cells.
Partial reprogramming by cyclical overexpression of Yamanaka factors improves pathological phenotypes of tauopathy mouse
In vivo partial reprogramming by bacteria promotes adult liver organ growth without fibrosis and tumorigenesis.
Deconstructing networks of p53-mediated tumor suppression in vivo
Senescence and cancer — role and therapeutic opportunities
Drug delivery systems for RNA therapeutics
Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs
RNA delivery by extracellular vesicles in mammalian cells and its applications
Genetic determinants and epigenetic effects of pioneer-factor occupancy
In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice.
Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation.
Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation.
Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation.
Restoration of neuronal progenitors by partial reprogramming in the aged neurogenic niche.
Partial reprogramming of the mammalian brain.
Fibroblast rejuvenation by mechanical reprogramming and redifferentiation
Precision Reprogramming-Restoring Function to Aged Cells.
Rejuvenation of Cardiac Tissue Developed from Reprogrammed Aged Somatic Cells.
Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice.
The Role of Epigenetics in Accelerated Aging: A Reconsideration of Later-Life Visual Loss After Early Optic Neuropathy.
Multi‐omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming
Transcriptional activation of endogenous Oct4 via the CRISPR / dCas9 activator ameliorates Hutchinson‐Gilford progeria s
Senescence promotes in vivo reprogramming through p16 INK 4a and IL ‐6
Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity.
Partial reprogramming strategy for intervertebral disc rejuvenation by activating energy switch.
Adult Sox2+ stem cell exhaustion in mice results in cellular senescence and premature aging.
Partial cellular reprogramming: A deep dive into an emerging rejuvenation technology.
Hippocampal rejuvenation by a single intracerebral injection of one-carbon metabolites in C57BL6 old wild-type mice.
Control of cell death and mitochondrial fission by ERK 1/2 MAP kinase signalling
A molecular signature defining exercise adaptation with ageing and in vivo partial reprogramming in skeletal muscle.
Partial in vivo reprogramming enables injury-free intestinal regeneration via autonomous Ptgs1 induction.
Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging.
Lineage Plasticity in Cancer Progression and Treatment
Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Di
Reprogramming Müller Glia to Regenerate Retinal Neurons
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
Effect on Multipotency and Phenotypic Transition of Unrestricted Somatic Stem Cells from Human Umbilical Cord Blood afte
Single-Short Partial Reprogramming of the Endothelial Cells Decreases Blood Pressure via Attenuation of EndMT in Hyperte
Long Live Partial Reprogramming.
Next-generation direct reprogramming.
Akt Protein Kinase, miR-200/miR-182 Expression and Epithelial-Mesenchymal Transition Proteins in Hibernating Ground Squi
Initiation phase cellular reprogramming ameliorates DNA damage in the ERCC1 mouse model of premature aging.
Cellular Senescence and Ageing: Mechanisms and Interventions
The dark side of SOX2: cancer - a comprehensive overview
Radiation-induced senescence: therapeutic opportunities
GATA3-dependent cellular reprogramming requires activation-domain dependent recruitment of a chromatin remodeler
Chemically induced reprogramming to reverse cellular aging
Heterochromatin: an epigenetic point of view in aging
In vivo reprogramming drives Kras-induced cancer development
Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in hum
The long and winding road of reprogramming-induced rejuvenation.
Validation of Common Housekeeping Genes as Reference for qPCR Gene Expression Analysis During iPS Reprogramming Process
Chemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan.
Zebrafish Müller glia-derived progenitors are multipotent, exhibit proliferative biases and regenerate excess neurons
A Single-Short Partial Reprogramming of the Endothelial Cells decreases Blood Pressure via attenuation of EndMT in Hyper
Initiation phase cellular reprogramming ameliorates DNA damage in the ERCC1 mouse model of premature aging.
jinling0122@pusan.ac.kr
The interplay of cellular senescence and reprogramming shapes the biological landscape of aging and cancer revealing nov
dr_shakra@azhar.edu.eg
Tissue nanotransfection and cellular reprogramming in regenerative medicine and antimicrobial dynamics.
gele_liu@rush.edu
Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications
vgladyshev@rics.bwh.harvard.edu
Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation.
vonmeyenn@babraham.ac.uk
Multi-tissue DNA methylation age predictor in mouse
chandra@igmm.ed.ac.uk
Cellular reprogramming and epigenetic rejuvenation
kangsheng2008@163.com.
Decoding Aging through iPSC Reprogramming: Advances and Challenges
kostas.kostarelos@manchester.ac.uk
Transient reprogramming of postnatal cardiomyocytes to a dedifferentiated state.
sheng.ding@gladstone.ucsf.edu
Human pancreatic beta-like cells converted from fibroblasts
hingtgen@email.unc.edu
Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma
blkimjk@postech.ac.kr
Partial <i>in vivo</i> reprogramming enables injury-free intestinal regeneration via autonomous Ptgs1 induction
david.suter@epfl.ch
A role for mitotic bookmarking of SOX2 in pluripotency and differentiation